Drug profile · INN
rubitecan
ORATHECIN
rubitecan (ORATHECIN) is a dna topoisomerase i inhibitor.
EMA: application withdrawn
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — rubitecan
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.83
Quick answer
rubitecan (ORATHECIN) is a dna topoisomerase i inhibitor.
Key facts
INN rubitecan
Brand ORATHECIN
Mechanism DNA topoisomerase I inhibitor
Target DNA topoisomerase 1
Mechanism of action
DNA topoisomerase I inhibitor
Primary target: DNA topoisomerase 1
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | application withdrawn | — |
Related & competitor drugs
Frequently asked questions
What is rubitecan?
rubitecan (ORATHECIN) is a dna topoisomerase i inhibitor.
What is the brand name for rubitecan?
ORATHECIN is a marketed brand name for rubitecan. Check FDA Drugs@FDA for the current US label holder and prescribing information.